Zepbound: FDA approves Eli Lilly's diabetes drug Mounjaro for obesity under new name

The US Food and Drug Administration approved the type 2 diabetes drug tirzepatide for use in chronic weight management Wednesday, making official the use of a medicine already widely prescribed off-label for weight loss.

Related Keywords

United States ,Eli Lilly ,John Sharretts ,Division Of Diabetes ,Drug Administration ,Lipid Disorders ,